Global RNAi for Therapeutic Market Size, Status and Forecast 2022
This report studies the global RNAi for Therapeutic market, analyzes and researches the RNAi for Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Alnylam Pharmaceuticals
- Arbutus Biopharma(Tekmira)
- Arrowhead Research
- Dicerna Pharmaceuticals
- Mirna Therapeutics
- Quark Pharmaceuticals
- RXi Pharmaceuticals
- Silence Therapeutics
- Benitec Biopharma
- miRagen Therapeutics
- Sylentis
- Gradalis
- Sirnaomics
- Silenseed
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- siRNA
- miRNA
- shRNA
- Cancer
- Cardiovascular
- HBV
- Other
Global RNAi for Therapeutic Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF RNAI FOR THERAPEUTIC
1.1 RNAi for Therapeutic Market Overview
1.1.1 RNAi for Therapeutic Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNAi for Therapeutic Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 RNAi for Therapeutic Market by Type
1.3.1 siRNA
1.3.2 miRNA
1.3.3 shRNA
1.4 RNAi for Therapeutic Market by End Users/Application
1.4.1 Cancer
1.4.2 Cardiovascular
1.4.3 HBV
1.4.4 Other
2 GLOBAL RNAI FOR THERAPEUTIC COMPETITION ANALYSIS BY PLAYERS
2.1 RNAi for Therapeutic Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arbutus Biopharma(Tekmira)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Arrowhead Research
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Mirna Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Quark Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 RXi Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Silence Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Benitec Biopharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 miRagen Therapeutics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Sylentis
3.12 Gradalis
3.13 Sirnaomics
3.14 Silenseed
4 GLOBAL RNAI FOR THERAPEUTIC MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global RNAi for Therapeutic Market Size by Type (2012-2017)
4.2 Global RNAi for Therapeutic Market Size by Application (2012-2017)
4.3 Potential Application of RNAi for Therapeutic in Future
4.4 Top Consumer/End Users of RNAi for Therapeutic
5 UNITED STATES RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
5.1 United States RNAi for Therapeutic Market Size (2012-2017)
5.2 United States RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
6 EU RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
6.1 EU RNAi for Therapeutic Market Size (2012-2017)
6.2 EU RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
7 JAPAN RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan RNAi for Therapeutic Market Size (2012-2017)
7.2 Japan RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
8 CHINA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
8.1 China RNAi for Therapeutic Market Size (2012-2017)
8.2 China RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
9 INDIA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
9.1 India RNAi for Therapeutic Market Size (2012-2017)
9.2 India RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia RNAi for Therapeutic Market Size (2012-2017)
10.2 Southeast Asia RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global RNAi for Therapeutic Market Size (Value) by Regions (2017-2022)
11.1.1 United States RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.2 EU RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.3 Japan RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.4 China RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.5 India RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.2 Global RNAi for Therapeutic Market Size (Value) by Type (2017-2022)
11.3 Global RNAi for Therapeutic Market Size by Application (2017-2022)
12 RNAI FOR THERAPEUTIC MARKET DYNAMICS
12.1 RNAi for Therapeutic Market Opportunities
12.2 RNAi for Therapeutic Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 RNAi for Therapeutic Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 RNAi for Therapeutic Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF RNAI FOR THERAPEUTIC
1.1 RNAi for Therapeutic Market Overview
1.1.1 RNAi for Therapeutic Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNAi for Therapeutic Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 RNAi for Therapeutic Market by Type
1.3.1 siRNA
1.3.2 miRNA
1.3.3 shRNA
1.4 RNAi for Therapeutic Market by End Users/Application
1.4.1 Cancer
1.4.2 Cardiovascular
1.4.3 HBV
1.4.4 Other
2 GLOBAL RNAI FOR THERAPEUTIC COMPETITION ANALYSIS BY PLAYERS
2.1 RNAi for Therapeutic Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arbutus Biopharma(Tekmira)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Arrowhead Research
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Mirna Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Quark Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 RXi Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Silence Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Benitec Biopharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 miRagen Therapeutics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Sylentis
3.12 Gradalis
3.13 Sirnaomics
3.14 Silenseed
4 GLOBAL RNAI FOR THERAPEUTIC MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global RNAi for Therapeutic Market Size by Type (2012-2017)
4.2 Global RNAi for Therapeutic Market Size by Application (2012-2017)
4.3 Potential Application of RNAi for Therapeutic in Future
4.4 Top Consumer/End Users of RNAi for Therapeutic
5 UNITED STATES RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
5.1 United States RNAi for Therapeutic Market Size (2012-2017)
5.2 United States RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
6 EU RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
6.1 EU RNAi for Therapeutic Market Size (2012-2017)
6.2 EU RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
7 JAPAN RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan RNAi for Therapeutic Market Size (2012-2017)
7.2 Japan RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
8 CHINA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
8.1 China RNAi for Therapeutic Market Size (2012-2017)
8.2 China RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
9 INDIA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
9.1 India RNAi for Therapeutic Market Size (2012-2017)
9.2 India RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA RNAI FOR THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia RNAi for Therapeutic Market Size (2012-2017)
10.2 Southeast Asia RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global RNAi for Therapeutic Market Size (Value) by Regions (2017-2022)
11.1.1 United States RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.2 EU RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.3 Japan RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.4 China RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.5 India RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2017-2022)
11.2 Global RNAi for Therapeutic Market Size (Value) by Type (2017-2022)
11.3 Global RNAi for Therapeutic Market Size by Application (2017-2022)
12 RNAI FOR THERAPEUTIC MARKET DYNAMICS
12.1 RNAi for Therapeutic Market Opportunities
12.2 RNAi for Therapeutic Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 RNAi for Therapeutic Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 RNAi for Therapeutic Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure RNAi for Therapeutic Product Scope
Figure Global RNAi for Therapeutic Market Size (Million USD) (2012-2017)
Table Global RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Regions in 2016
Figure United States RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Type in 2016
Figure siRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure miRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure shRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Application in 2016
Table Key Downstream Customer in Cancer
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Cancer (2012-2017)
Table Key Downstream Customer in Cardiovascular
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
Table Key Downstream Customer in HBV
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in HBV (2012-2017)
Table Key Downstream Customer in Other
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table RNAi for Therapeutic Market Size (Million USD) by Players (2016 and 2017)
Figure RNAi for Therapeutic Market Size Share by Players in 2016
Figure RNAi for Therapeutic Market Size Share by Players in 2017
Table Alnylam Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Alnylam Pharmaceuticals (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Arbutus Biopharma(Tekmira) Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Arbutus Biopharma(Tekmira) (2012-2017)
Figure Arbutus Biopharma(Tekmira) RNAi for Therapeutic Business Revenue Market Share in 2016
Table Arrowhead Research Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Arrowhead Research (2012-2017)
Figure Arrowhead Research RNAi for Therapeutic Business Revenue Market Share in 2016
Table Dicerna Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Dicerna Pharmaceuticals (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Mirna Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Mirna Therapeutics (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Quark Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Quark Pharmaceuticals (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table RXi Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of RXi Pharmaceuticals (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Silence Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Silence Therapeutics (2012-2017)
Figure Silence Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Benitec Biopharma Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Benitec Biopharma (2012-2017)
Figure Benitec Biopharma RNAi for Therapeutic Business Revenue Market Share in 2016
Table miRagen Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of miRagen Therapeutics (2012-2017)
Figure miRagen Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Sylentis Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Sylentis (2012-2017)
Figure Sylentis RNAi for Therapeutic Business Revenue Market Share in 2016
Table Gradalis Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Gradalis (2012-2017)
Figure Gradalis RNAi for Therapeutic Business Revenue Market Share in 2016
Table Sirnaomics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Sirnaomics (2012-2017)
Figure Sirnaomics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Silenseed Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Silenseed (2012-2017)
Figure Silenseed RNAi for Therapeutic Business Revenue Market Share in 2016
Table Global RNAi for Therapeutic Market Size (Million USD) by Type (2012-2017)
Figure Global RNAi for Therapeutic Market Size Share by Type in 2012
Figure Global RNAi for Therapeutic Market Size Share by Type in 2013
Figure Global RNAi for Therapeutic Market Size Share by Type in 2014
Figure Global RNAi for Therapeutic Market Size Share by Type in 2015
Figure Global RNAi for Therapeutic Market Size Share by Type in 2016
Figure Global RNAi for Therapeutic Market Size Share by Type in 2017
Table Global RNAi for Therapeutic Market Size (Million USD) by Application (2012-2017)
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2012
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2013
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2014
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2015
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2016
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of RNAi for Therapeutic
Figure United States RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure United States RNAi for Therapeutic Market Size Share by Players in 2016
Figure United States RNAi for Therapeutic Market Size Share by Players in 2017
Figure EU RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure EU RNAi for Therapeutic Market Size Share by Players in 2016
Figure EU RNAi for Therapeutic Market Size Share by Players in 2017
Figure Japan RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Japan RNAi for Therapeutic Market Size Share by Players in 2016
Figure Japan RNAi for Therapeutic Market Size Share by Players in 2017
Figure China RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure China RNAi for Therapeutic Market Size Share by Players in 2016
Figure China RNAi for Therapeutic Market Size Share by Players in 2017
Figure India RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure India RNAi for Therapeutic Market Size Share by Players in 2016
Figure India RNAi for Therapeutic Market Size Share by Players in 2017
Figure Southeast Asia RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Market Size Share by Players in 2016
Figure Southeast Asia RNAi for Therapeutic Market Size Share by Players in 2017
Figure Global RNAi for Therapeutic Market Size (Million USD) by Regions (2017-2022)
Table Global RNAi for Therapeutic Market Size (Million USD) by Regions (2017-2022)
Figure Global RNAi for Therapeutic Market Size Share by Regions in 2017
Figure Global RNAi for Therapeutic Market Size Share by Regions in 2022
Figure United States RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Table Global RNAi for Therapeutic Market Size (Million USD) by Type (2017-2022)
Figure Global RNAi for Therapeutic Market Size Share by Type in 2017
Figure Global RNAi for Therapeutic Market Size Share by Type in 2022
Table Global RNAi for Therapeutic Market Size (Million USD) by Application (2017-2022)
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2017
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2022
Figure RNAi for Therapeutic Product Scope
Figure Global RNAi for Therapeutic Market Size (Million USD) (2012-2017)
Table Global RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Regions in 2016
Figure United States RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Type in 2016
Figure siRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure miRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure shRNA Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global RNAi for Therapeutic Market Share by Application in 2016
Table Key Downstream Customer in Cancer
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Cancer (2012-2017)
Table Key Downstream Customer in Cardiovascular
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
Table Key Downstream Customer in HBV
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in HBV (2012-2017)
Table Key Downstream Customer in Other
Figure RNAi for Therapeutic Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table RNAi for Therapeutic Market Size (Million USD) by Players (2016 and 2017)
Figure RNAi for Therapeutic Market Size Share by Players in 2016
Figure RNAi for Therapeutic Market Size Share by Players in 2017
Table Alnylam Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Alnylam Pharmaceuticals (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Arbutus Biopharma(Tekmira) Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Arbutus Biopharma(Tekmira) (2012-2017)
Figure Arbutus Biopharma(Tekmira) RNAi for Therapeutic Business Revenue Market Share in 2016
Table Arrowhead Research Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Arrowhead Research (2012-2017)
Figure Arrowhead Research RNAi for Therapeutic Business Revenue Market Share in 2016
Table Dicerna Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Dicerna Pharmaceuticals (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Mirna Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Mirna Therapeutics (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Quark Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Quark Pharmaceuticals (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table RXi Pharmaceuticals Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of RXi Pharmaceuticals (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Business Revenue Market Share in 2016
Table Silence Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Silence Therapeutics (2012-2017)
Figure Silence Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Benitec Biopharma Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Benitec Biopharma (2012-2017)
Figure Benitec Biopharma RNAi for Therapeutic Business Revenue Market Share in 2016
Table miRagen Therapeutics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of miRagen Therapeutics (2012-2017)
Figure miRagen Therapeutics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Sylentis Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Sylentis (2012-2017)
Figure Sylentis RNAi for Therapeutic Business Revenue Market Share in 2016
Table Gradalis Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Gradalis (2012-2017)
Figure Gradalis RNAi for Therapeutic Business Revenue Market Share in 2016
Table Sirnaomics Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Sirnaomics (2012-2017)
Figure Sirnaomics RNAi for Therapeutic Business Revenue Market Share in 2016
Table Silenseed Basic Information List
Table RNAi for Therapeutic Business Revenue (Million USD) of Silenseed (2012-2017)
Figure Silenseed RNAi for Therapeutic Business Revenue Market Share in 2016
Table Global RNAi for Therapeutic Market Size (Million USD) by Type (2012-2017)
Figure Global RNAi for Therapeutic Market Size Share by Type in 2012
Figure Global RNAi for Therapeutic Market Size Share by Type in 2013
Figure Global RNAi for Therapeutic Market Size Share by Type in 2014
Figure Global RNAi for Therapeutic Market Size Share by Type in 2015
Figure Global RNAi for Therapeutic Market Size Share by Type in 2016
Figure Global RNAi for Therapeutic Market Size Share by Type in 2017
Table Global RNAi for Therapeutic Market Size (Million USD) by Application (2012-2017)
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2012
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2013
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2014
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2015
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2016
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of RNAi for Therapeutic
Figure United States RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure United States RNAi for Therapeutic Market Size Share by Players in 2016
Figure United States RNAi for Therapeutic Market Size Share by Players in 2017
Figure EU RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure EU RNAi for Therapeutic Market Size Share by Players in 2016
Figure EU RNAi for Therapeutic Market Size Share by Players in 2017
Figure Japan RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Japan RNAi for Therapeutic Market Size Share by Players in 2016
Figure Japan RNAi for Therapeutic Market Size Share by Players in 2017
Figure China RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure China RNAi for Therapeutic Market Size Share by Players in 2016
Figure China RNAi for Therapeutic Market Size Share by Players in 2017
Figure India RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure India RNAi for Therapeutic Market Size Share by Players in 2016
Figure India RNAi for Therapeutic Market Size Share by Players in 2017
Figure Southeast Asia RNAi for Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia RNAi for Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia RNAi for Therapeutic Market Size Share by Players in 2016
Figure Southeast Asia RNAi for Therapeutic Market Size Share by Players in 2017
Figure Global RNAi for Therapeutic Market Size (Million USD) by Regions (2017-2022)
Table Global RNAi for Therapeutic Market Size (Million USD) by Regions (2017-2022)
Figure Global RNAi for Therapeutic Market Size Share by Regions in 2017
Figure Global RNAi for Therapeutic Market Size Share by Regions in 2022
Figure United States RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Table Global RNAi for Therapeutic Market Size (Million USD) by Type (2017-2022)
Figure Global RNAi for Therapeutic Market Size Share by Type in 2017
Figure Global RNAi for Therapeutic Market Size Share by Type in 2022
Table Global RNAi for Therapeutic Market Size (Million USD) by Application (2017-2022)
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2017
Figure Global RNAi for Therapeutic Market Size (Million USD) by Application in 2022
